0001140361-18-016002.txt : 20180329
0001140361-18-016002.hdr.sgml : 20180329
20180329205047
ACCESSION NUMBER: 0001140361-18-016002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180328
FILED AS OF DATE: 20180329
DATE AS OF CHANGE: 20180329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORE ROBERT J
CENTRAL INDEX KEY: 0001207792
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38155
FILM NUMBER: 18724599
MAIL ADDRESS:
STREET 1: 2285 W. WHITE PINE LANE
CITY: PARK CITY
STATE: UT
ZIP: 84060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sienna Biopharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001656328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273364627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
BUSINESS PHONE: (818) 629-2256
MAIL ADDRESS:
STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
FORMER COMPANY:
FORMER CONFORMED NAME: Sienna Labs, Inc.
DATE OF NAME CHANGE: 20151020
4
1
doc1.xml
FORM 4
X0306
4
2018-03-28
0
0001656328
Sienna Biopharmaceuticals, Inc.
SNNA
0001207792
MORE ROBERT J
C/O SIENNA BIOPHARMACEUTICALS, INC.
30699 RUSSELL RANCH ROAD, SUITE 140
WESTLAKE VILLAGE
CA
91362
1
0
0
0
Common Stock
2018-03-28
4
S
0
10000
18.84
D
193249
D
Common Stock
2018-03-29
4
S
0
14429
18.78
D
178820
D
This transaction was executed in multiple trades in prices ranging from $18.8213 to $18.869, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $18.75 to $18.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Timothy K. Andrews, attorney-in-fact for Robert J. More
2018-03-29